Moderna NASDAQ: MRNAI only ever got a few entries onto this position early on and have taken profit along the way mainly due to freaking me out with the volatility when we started spiking to 200 dollars back at the end of 2020.
I chose to play some of the bio tech and pharma plays during early covid as a defensive play but also some high risk as the controversy around the vaccines could have significantly back fire on me but I took the punt anyway.
As I mentioned I havent taken any new entries since jan 2021 and just riding what i have left now, but its one of those stocks that just keeps running for me with regret of not going in heavier or not taking profit early with partial position lol but thats the game isnt it, hindsight's a bitch.
Not doing any fancy TA on this, simply just following the channels up and looking for reaction on the outer limit of the pitchfork (set to 1.618) any major break down of the mean and I may look for a top up but I feel its gone far enough and actually looking to de-risk soon and reduce position further.
Probably going to bite me in ass here
PHARMA
Vertex, a great pharmaceutical at a discounted priceA company with over 10 years of consistent and constant growth, a wide coverage of products already on the market and... despite an excellent quarterly for a news or a trail .. boom .. It drops suddenly ?
In my opinion this is sheer market madness, the sites I use as a reference for fundamental analysis confirm to me what I say, the company always be more than 50% below its fair value.
To confirm my conviction is also Market Miracle the algorithmic advisor, which has provided an entry signal on the stock at the price of 188 usd, also providing a valuable indication ... that is, that the price of the stock is in the area of oversold.
In the immediate I don’t expect a great climb but given the solidity of the company is definitely a low-risk investment that, given the discounted price can also lead to very interesting gains in the medium term ... obviously if the price starts to rise.
So I decided to increase the positions on Vertex Pharmaceuticals $VRTX hoping to be on the side of the market that as you know always has the reason on its side.
This idea is based on a signal generated by the advisor Marketmiracle, down on this page you will find the link to the page of signals of the advisor that you can see for free without any cost or registration
Are we close to observe a breakout on NVAX ?Novavax COVID-19 vaccine more than 90% effective in U.S trial according to Reuters. Despite positive news (which we do not trade), we will share with you our current view on Novavax.
a) The price is inside a descending Wedge, and due to positive news, we are observing a bullish GAP, and we may see the price outside the Wedge pattern
b) The general strategy we will use to develop bullish setups on the pharmaceutical company is waiting for the price to reach 250 - 270 and then an ABC corrective pattern, as you can see on the chart.
c) IF that scenario happens, we will trade above B, and our stop loss will be set below C
d) Regarding the targets, we will be using the Fibo Extensions of the major descending wedge
Thanks for reading!
CIPLAAfter doing a consolidation near the 1st target of a Bullish Harmonic Dragon, it now appears to have resumed its rally for the 2nd target near 1000. The view would be negated below 940
Dragon Patterns are HARMONIC target probabilities of Double Bottoms and Double Tops. They are among the few rare Harmonic patterns which are continuation patterns rather than the usual reversal signals, Harmonic Patterns are more popularly used for.
Pharma Patent Law Party Time!! $PHRRFSo here's my guess for the next short term bout of fun and awesome small cap volatility! Seriously though, I like how this company operates so far. Protective patents have been filed, they've already set up plenty of partnerships to get clinical trials rolling, and the blue-sky potential here is pretty staggering. No, really, it's suspiciously good. I'm obviously kinda dumb though, so it could just be a "stuck in my own thrall" kinda situation.
Ok for starters, I'll admit that I don't care about the patent stuff. I'll explain why: I'm confident that the microneedle patch is protective enough that the whole issue of 'method of treatment' patents is negligible. But everyone is going to see "Clinical Trials for Big Disease! Big Yes!" Then they see it's for a generic drug and are all, "well that isn't how you print money!" and they scurry back into their dark abyss. Ok, so say it with me: " proprietary patch is patent protected."
Don't worry, I'm totally gonna forget, too!
But even aside from that, there is a (relatively-recent!) precedent set for patent protections in regards to "Methods of Treatment." It's a whole 'thing' that I'm not qualified to talk about, but I'm doing my own due diligence. Without looking though, I can say that a court case settled in 2018 is new by law standards, and new laws are frequently subject to challenges. For this reason, I'm gonna go ahead and anticipate a (temporary, brief) further drop in share price until everyone brushes up on the relevant patent cases.
When everyone's homework gets turned in, I'm thinking we'll see $0.45USD.
Idk, I really like when projected patterns line up with good fundamental markers- bonus points for ending on or near pretty, round numbers. I've gotta admit though, it's definitely feels like a stupid way to think, so it's probably dangerous to share the notion. Caveat stultus and all that.
Regardless, the company still has a ridiculously small market cap when compared to other equivalent players in the psychedelic pharmaceutical space. Yeah, even after the recent gains. (To be fair, it could just mean that everyone else has much more room to fall.)
Anyway! Let me know if I need to stop! :)
HOOK General/Rough Short Position Analysis Overall:
* Negative EPS
* June 7th conference @ASCO will most likely lead to a double-top.
* The "surge" is starting to end, if not has already ended. Share price should return to anywhere between $8-11, possibly even lower.
* Medical breakthroughs, as a whole, when it comes to cancers, which this company focuses on, are slow, unlikely, and uncommon. And I suspect, the share price will not be Mooning, anytime soon.
Long trade on Elixinol Global (EXL)This trade truly is the epitome of risk:reward. If you look at Creso Pharma (CPH) in October-December of 2020, you will note EXL is mirroring similar price action. What this means, is that EXL is literally trading at all-time lows, and this takes into consideration the 2020 Covid Crash. I am currently in this trade with two (2) entries, one at $0.19 and another at $0.15. I will be holding this trade long term in anticipation of positive news regarding decriminalisation in the US, Canada, Europe, UK and subsequently Australia.
Good luck traders. Manage your risk.
AartiDrugsTimeFrame - Weekly
AartiDrugs is trading in a range for the past few weeks, closing above range can give fresh BO.
Weekly RSI has just crossed 60 - Showing strength
Once Breakout happens, once can go along with SL 700 weekly closing basis.
Disclaimer
I am not SEBI registered analyst
My studies are Educational purpose only
Please consult with your financial advisor before trading or investing
Genmab opportunitysteamloss in the Genmab stock will likely fuel a new rush.
1) the 2 previous times times RSI has been below 30, it has resulted in strong returns. Will it happen a 3rd time?
2) The current strongly rising RSI will like make sure that the price will move and stay above the short term downward trend.
3) Opportunity for the price to move towards 2557 DKK. Yet be aware of potential strong resistance around 2364 DKK.
4) If this small up trend can offset the short term setback, 50/200 will likely trigger a new golden cross.
Entered long in 2168 DKK
Syndax is about to see huge gains to ~$24 a share again. Syndax Pharmaceuticals recently had POSITIVE interim data on their phase 2 study in SNDX-5613 for Leukemia. This data was positive as they saw a 48% overall response rate in patients with MLLr or NPM1c; 67% of responders achieved minimal residual disease-negative status. Out of 43 of patients evaluated, 31 were able to be used as for significant data. These two pieces of news are huge as Leukemia is an extremely life threatening disease where more than 50% of people are dead within 5 years. Any drug that can help save these peoples lives is priceless and the upside of this company is definitely there. I believe the sell off was a big Hedge fund taking their profits and exiting as they were not satisfied with the Positive results from the study, causing stop losses and further panic selling. This has also caused an overcorrection in the stock price which should correct once another big player enters and brings the rest of the bulls with them.
There is a rough bottom at $13 currently on the stock and it is possible for the stock to go down further as this is simply my opinion and is for educational purposes only.
Piggyback the profiteers After some conversation with a young single mom and what she goes through to get her and her 2 yr old diabetes meds @ $13hr...f to the big pharma and f to the health care that does not cover such a life saving drug. It's not a conspiracy...it's a cultural failure to recognize how far we have come in such a short time. Some will call it profiteering...sure but it's also about what is done with those profits...what could be done. So I'm in on medtronic with the mission to take their pillaging and raping of the target audience, get some profits and help someone that needs help with their medication.
www.diabetes.ca you can donate as well....I just want to take the strain off someone I know personally.